Clinical trials of peripheral stage I (T1N0M0) non-small cell lung cancer
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 15 (4) , 421-430
- https://doi.org/10.1053/j.semtcvs.2003.09.003
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non–small-cell lung cancerSurgery, 2003
- Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lungCancer, 2003
- Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimensionCancer, 2003
- State of the art in thoracoscopic surgerySurgical Endoscopy, 2002
- Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor PrognosisAnnals of Surgical Oncology, 2001
- The clinical significance of hepatocyte growth factor for non–small cell lung cancerThe Annals of Thoracic Surgery, 1998
- Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Iodine125 interstitial brachytherapy in the treatment of carcinoma of the lungJournal of Surgical Oncology, 1992
- Survival after conservative resection for T1 N0 M0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1990
- Limited Resection of Bronchogenic Carcinoma in the Patient with Marked Impairment of Pulmonary FunctionThe Annals of Thoracic Surgery, 1987